text_1: AMP-activated protein kinase (AMPK) activation increases inflammation-related fibrosis in the lungs.
text_2: These studies implicate deficient AMPK activation in non-resolving, pathologic fibrotic processes, and support a role for metformin (or other AMPK activators) to reverse established fibrosis by facilitating deactivation and apoptosis of myofibroblasts.